Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Selective leukemic-cell killing by a novel functional class of thalidomide analogs

Yun Ge, Idalia Montano, Gabriella Rustici, Wendy J. Freebern, Cynthia M. Haggerty, Wenwu Cui, Damaris Ponciano-Jackson, G. V. R. Chandramouli, Erin R. Gardner, William D. Figg, Mones Abu-Asab, Maria Tsokos, Sharon H. Jackson, Kevin Gardner

Blood (2006) 108 (13): 4126–4135.

https://doi.org/10.1182/blood-2006-04-017046

Published: 2006

Includes: Multimedia, Supplemental data

Journal Articles

Myeloma Cells Cultivate Megakaryocytes To Promote Lytic Bone Disease.

Shmuel Yaccoby, PhD, Rinku Saha, Ewa Kozlowska, Yun Ge, PhD, Wen Ling, Michele Cottler-Fox, MD, Bart Barlogie, MD, PhD, Guido Tricot, MD

Blood (2005) 106 (11): 2495.

https://doi.org/10.1182/blood.V106.11.2495.2495

Published: 2005

Journal Articles

Reciprocal Interaction between Megakaryocytes and Myeloma Cells Results in Increased Survival and Proliferation of Myeloma Cells.

Shmuel Yaccoby, PhD, Rinku Saha, Ewa Kozlowska, Yun Ge, PhD, Wen Ling, Michele Cottler-Fox, MD, Bart Barlogie, MD, PhD, Guido Tricot, MD

Blood (2005) 106 (11): 628.

https://doi.org/10.1182/blood.V106.11.628.628

Published: 2005

Journal Articles

Role of Osteoclasts in Regulation of Human Hematopoietic Stem Cell Niche and Fate.

Shmuel Yaccoby, PhD, Kenichiro Yata, MD, Yun Ge, PhD, Bart Barlogie, MD, PhD, Joshua Epstein, DSc, Guido Tricot, MD

Blood (2004) 104 (11): 4253.

https://doi.org/10.1182/blood.V104.11.4253.4253

Published: 2004

Journal Articles

The Plasticity of Myeloma Plasma Cells as Expressed by Dedifferentiation into an Immature, Resilient, Apoptosis-Resistant Phenotype.

Shmuel Yaccoby, PhD, Kenichiro Yata, MD, Yun Ge, PhD, Bart Barlogie, MD, PhD, Guido Tricot, MD, Joshua Epstein, DSc

Blood (2004) 104 (11): 633.

https://doi.org/10.1182/blood.V104.11.633.633

Published: 2004

Journal Articles

Fibroblast Activation Protein (FAP) Is a Critical Microenvironmental Survival Factor for Myeloma Plasma Cells.

Yun Ge, PhD, Fenghuang Zhan, PhD, John Shaughnessy, PhD, Bart Barlogie, MD, Guido Tricot, MD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD

Blood (2004) 104 (11): 634.

https://doi.org/10.1182/blood.V104.11.634.634

Published: 2004

NARROW

Selective leukemic-cell killing by a novel functional class of thalidomide analogs

Myeloma Cells Cultivate Megakaryocytes To Promote Lytic Bone Disease.

Reciprocal Interaction between Megakaryocytes and Myeloma Cells Results in Increased Survival and Proliferation of Myeloma Cells.

Role of Osteoclasts in Regulation of Human Hematopoietic Stem Cell Niche and Fate.

The Plasticity of Myeloma Plasma Cells as Expressed by Dedifferentiation into an Immature, Resilient, Apoptosis-Resistant Phenotype.

Fibroblast Activation Protein (FAP) Is a Critical Microenvironmental Survival Factor for Myeloma Plasma Cells.

Email alerts

ASH Publications

American Society of Hematology

Selective leukemic-cell killing by a novel functional class of thalidomide analogs

Myeloma Cells Cultivate Megakaryocytes To Promote Lytic Bone Disease.

Reciprocal Interaction between Megakaryocytes and Myeloma Cells Results in Increased Survival and Proliferation of Myeloma Cells.

Role of Osteoclasts in Regulation of Human Hematopoietic Stem Cell Niche and Fate.

The Plasticity of Myeloma Plasma Cells as Expressed by Dedifferentiation into an Immature, Resilient, Apoptosis-Resistant Phenotype.

Fibroblast Activation Protein (FAP) Is a Critical Microenvironmental Survival Factor for Myeloma Plasma Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only